Next Article in Journal
Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
Next Article in Special Issue
INGAP-Peptide Variants as a Novel Therapy for Type 1 Diabetes: Effect on Human Islet Insulin Secretion and Gene Expression
Previous Article in Journal
In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals
Previous Article in Special Issue
Host Response Modulation Therapy in the Diabetes Mellitus—Periodontitis Conjuncture: A Narrative Review
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(8), 1730; https://doi.org/10.3390/pharmaceutics14081730
Action Date Notes Link
article xml file uploaded 18 August 2022 15:21 CEST Original file -
article xml uploaded. 18 August 2022 15:21 CEST Update https://www.mdpi.com/1999-4923/14/8/1730/xml
article pdf uploaded. 18 August 2022 15:21 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1730/pdf
article html file updated 18 August 2022 15:23 CEST Original file https://www.mdpi.com/1999-4923/14/8/1730/html
Back to TopTop